Maternal serum CA125 and CA15-3 antigen levels in normal and pathological pregnancy

Fetal Diagnosis and Therapy

Volumn 16, Issue 3, 2001, Pages 166-172

  Bon, G G ^a   Kenemans, P ^a   Verstraeten, A A ^a   Go, S ^a   Philipi, P A ^a   Van Kamp, G J ^a   Van Geijn, H P ^a   Van Vugt, J M G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fetoprotein; CA125; CA15 3; Maternal serum levels; MUC1; Pregnancy; Prenatal diagnosis

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SPONTANEOUS ABORTION; STRUCTURAL CHROMOSOME ABERRATION; THIRD TRIMESTER PREGNANCY;

ABORTION, SPONTANEOUS; ADULT; CA-125 ANTIGEN; CA-15-3 ANTIGEN; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; PRENATAL DIAGNOSIS;

EID: 0035063407     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053903     Document Type: Article

References (25)

1. Review on the clinical value of polymorphic epithelial mucin tumor markers for the management of carcinoma patients
2. Increased serum CA125 levels during the first trimester of pregnancy
3. Maternal CA-125 levels in pregnancy and the puerperium
4. Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women
5. Technical and clinical evaluation of a new fully automated enzyme immunoassay for the detection of CA125, a multicenter study
6. Serum CA 125 levels in early pregnancy and subsequent spontaneous abortion
7. CA-125 is elevated in viable pregnancies destined to be miscarried: A prospective longitudinal study
8. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening for Down's syndrome
9. Fluctuations in CA125 and CA15-3 serum levels during spontaneous ovulatory cycles
10. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening
11. An association between low maternal serum alpha-fetoprotein and fetal chromosomal anomalies
12. The second generation CA 125 assays
13. Technical and clinical evaluation of a new automated CA 15-3 test
14. Estimating a woman's risk of having a pregnancy with Down's syndrome using her age and serum alpha-fetoprotein level
15. CA125 antigen levels in obstetric and gynecologic patients
16. CA-125 in tissues and amniotic fluid during pregnancy
17. A challenge to the concept of tubal reflux to explain the rise and fall of CA125 in serum during the first trimester
18. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid
19. Tumour marker antigens during menses and pregnancy
20. Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development
21. Modulation of MUC-1 mucin expression in the mouse uterus during the estrus cycle, early pregnancy and placentation
22. Radioimmunoassay of maternal serum alpha fetoprotein during pregnancy and delivery
23. Maternal serum CA 125 levels in pregnancies with chromosomally-normal and -abnormal fetuses
24. Amniotic fluid and maternal serum levels of CA125 in pregnancies affected by Down syndrome: A reevaluation of the role of CA125 in Down syndrome screening
25. Evaluation of serum cancer antigen CA 125 in pre-eclampsia